Abstract
Our study aimed to target adenoviral gene therapy to the uteroplacental circulation of pregnant Guinea pigs in order to develop a novel therapy for fetal growth restriction. Four methods of delivery of an adenovirus encoding β-galactosidase (Ad.LacZ) were evaluated: intravascular injection using phosphate-buffered saline (PBS) into (1) uterine artery (UtA) or (2) internal iliac artery or external administration in (3) PBS or (4) pluronic F-127 gel (Sigma Aldrich). Postmortem examination was performed 4 to 7 days after gene transfer. Tissue transduction was assessed by X-gal histochemistry and enzyme-linked immunosorbent assay. External vascular application of the adenovirus vector in combination with pluronic gel had 91.7% success rate in terms of administration (85% maternal survival) and gave the best results for maternal/fetal survival and local transduction efficiency without any spread to maternal or fetal tissues. This study suggests an optimal method of gene delivery to the UtAs of a small rodent for preclinical studies.
Original language | English |
---|---|
Pages (from-to) | 1087-1095 |
Number of pages | 9 |
Journal | Reproductive Sciences |
Volume | 23 |
Issue number | 8 |
DOIs | |
State | Published - 1 Aug 2016 |
Externally published | Yes |
Keywords
- Guinea pig
- VEGF-A
- adenovirus vector
- pluronic gel
- prenatal gene therapy
- uteroplacental circulation